Description
Sevelamer Hydrochloride (sevelamer hydrochloride) is a kidney health medications agent listed in our Kidney health medications directory and prescribed for specified kidney-related conditions (1.1) (2.1). Administered via the oral route, Sevelamer Hydrochloride is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Sevelamer Hydrochloride is a medication containing the active pharmaceutical ingredient sevelamer hydrochloride, classified pharmacologically as a kidney health medications agent (2.1). It is clinically indicated for the management of specified kidney-related conditions as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Kidney health medications section of our catalogue, patients and prescribers frequently review Sevelamer Hydrochloride alongside related therapies such as Renagel (Sevelamer Hydrochloride), Cyclosporine, Cytra K (Potassium Citrate / Citric Acid), and Darifenacin Hydrobromide.
Official Indications and Usage
Indications and usage Sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. The safety and efficacy of sevelamer hydrochloride tablets in CKD patients who are not on dialysis have not been studied. (1.1)
Mechanism of Action and Pharmacology
Sevelamer hydrochloride tablets contain sevelamer hydrochloride, a non-absorbed binding crosslinked polymer. It contains multiple amines separated by one carbon from the polymer backbone. These amines exist in a protonated form in the intestine and interact with phosphate molecules through ionic and hydrogen bonding. By binding phosphate in the dietary tract and decreasing absorption, sevelamer hydrochloride lowers the phosphate concentration in the serum. (1.1)
What is Chronic kidney disease?
Chronic kidney disease involves persistent kidney damage or reduced kidney function. Medicine choice and monitoring depend on kidney function and complications. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Chronic kidney disease condition guide for appointment questions and related therapies (2.1).
Ordering Sevelamer Hydrochloride from Canada for U.S. Delivery
U.S. patients can order Sevelamer Hydrochloride (Sevelamer) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Sevelamer Hydrochloride |
| Chemical / Generic Name | Sevelamer Hydrochloride |
| Pharmacological Class | Kidney health medications agent |
| Therapeutic Category | Kidney health medications |
| Same-Ingredient Catalogue Entries | Renagel (Sevelamer Hydrochloride) |
| Bioavailability | ~50% (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Oral |
| Dosage Forms & Strengths | 3. Dosage forms and strengths 400 mg Tablets: off-white to pale yellow, oval shaped, biconvex film-coated tablets, imprinted with ‘G446’ on one side and |
| Primary Indications | Specified Kidney-Related Conditions |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | GLS2PGI8QG |
| NLM RxNorm Concept ID (RxCUI) | 857224 |
| FDA Application License | ANDA204724 |
| Official DailyMed SetID | 8830526f-d957-423e-84ea-e4d79346948b |
| Catalogue Index Links | Letter S Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Dosage and administration Patients Not Taking a Phosphate Binder. The recommended starting dose of sevelamer hydrochloride tablets is 800 to 1600 mg, which can be administered as one or two 800 mg sevelamer hydrochloride tablets or two to four 400 mg sevelamer hydrochloride tablets, with meals based on serum phosphorus level. Starting Dose for Dialysis Patients Not Taking a Phosphate Binder Serum Phosphorus Sevelamer Hydrochloride Tablets 800 mg Sevelamer Hydrochloride Tablets 400 mg > 5.5 and < 7.5 mg/dL 1 tablet three times daily with meals 2 tablets three times daily with meals ≥ 7.5 and < 9 mg/dL 2 tablets three times daily with meals 3 tablets three times daily with meals ≥ 9 mg/dL 2 tablets three times daily with meals 4 tablets three times daily with meals Patients Switching from Calcium Acetate. (1.1)
Presentations and Strengths
Dosage forms and strengths 400 mg Tablets: off-white to pale yellow, oval shaped, biconvex film-coated tablets, imprinted with ‘G446’ on one side and plain on the other side. 800 mg Tablets: off-white to pale yellow, modified capsule shaped, biconvex film-coated tablets, imprinted with ‘G447’ on one side and plain on the other side. Tablets: 800 mg and 400 mg. (1.1)
Administration Guidance
Take Sevelamer Hydrochloride orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.
Missed Dose Guidance
If you miss a scheduled dose of Sevelamer Hydrochloride, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Sevelamer Hydrochloride is sevelamer hydrochloride (2.1). Other catalogue entries containing sevelamer hydrochloride include Renagel (Sevelamer Hydrochloride).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Contraindications
Contraindications Sevelamer hydrochloride is contraindicated in patients with bowel obstruction. Sevelamer hydrochloride tablets are contraindicated in patients with known hypersensitivity to sevelamer hydrochloride or to any of the excipients. (1.1)
Key Clinical Precautions
Before starting or continuing Sevelamer Hydrochloride, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Gastrointestinal ulceration, bleeding, and perforation: Serious gastrointestinal adverse events including inflammation, bleeding, ulceration, and perforation of the esophagus, stomach, or intestines can occur with or without warning symptoms.
Pregnancy, Lactation, and Special Populations
Sevelamer hydrochloride is not absorbed systemically following oral administration and maternal use is not expected to result in fetal exposure to the drug. Clinical Considerations Sevelamer hydrochloride may decrease serum levels of fat soluble vitamins and folic acid in pregnant women. Consider supplementing with these vitamins. Data Animal data In pregnant rats given dietary doses of 0.5, 1.5, or 4.5 g/kg/day of sevelamer hydrochloride during organogenesis, reduced or irregular ossification of fetal bones, probably due to a reduced absorption of fat-soluble vitamin D, occurred at 7-21 times the maximum human equivalent dose of 13 g based on 60 kg body weight. (1.1)
Interactions
Official Drug Interaction Overview
Drug interactions There are no empirical data on avoiding drug interactions between sevelamer hydrochloride and most concomitant oral drugs. For oral medication where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy (e.g., cyclosporine, tacrolimus, levothyroxine), consider separation of the timing of the administration of the two drugs. The duration of separation depends upon the absorption characteristics of the medication concomitantly administered, such as the time to reach peak systemic levels and whether the drug is an immediate-release or an extended-release product. Where possible monitor clinical responses or blood levels of concomitant drugs that have a narrow therapeutic range. (1.1)
Important Interaction Categories
Concomitant use of Sevelamer Hydrochloride with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Warfarin and vitamin K antagonists (such as Coumadin (Warfarin Sodium) or Warfarin Generic in our Cardiovascular directory): Concomitant administration may alter prothrombin time and International Normalized Ratio (INR) or have additive effects on hemostasis and bleeding risk. More frequent INR monitoring and clinical observation for bleeding are recommended.
- Digoxin (such as Lanoxin (Digoxin) or Digoxin Generic): Co-administration can affect P-glycoprotein transport or renal clearance of digoxin, altering serum digoxin concentrations. Appropriate clinical and laboratory monitoring of digoxin levels is advised.
- Cyclosporine and calcineurin inhibitors (such as cyclosporine or tacrolimus): Co-administration can alter drug transport (OATP1B1 or P-gp) or CYP metabolism, changing blood levels of either medication or increasing nephrotoxicity and myopathy risks.
Side effects
Like all medications, Sevelamer Hydrochloride can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
- Constipation: Adequate hydration and dietary fiber can help manage mild changes in bowel habits.
- Abdominal discomfort or stomach pain: Mild gastrointestinal upset may occur; report severe, persistent, or radiating abdominal pain promptly.
- Fatigue or tiredness: May occur during initial adjustment or dose changes.
Clinical Trial and Postmarketing Adverse Reactions
Adverse reactions The most common reasons for discontinuing treatment were gastrointestinal adverse reactions. In a parallel design study of 12 weeks duration, treatment emergent adverse reactions to sevelamer hydrochloride tablets in peritoneal dialysis patients included dyspepsia (12%), peritonitis (8%), diarrhea (5%), nausea (5%), constipation (4%), pruritus (4%), abdominal distension (3%), vomiting (3%), fatigue (3%), anorexia (3%), and arthralgia (3%). Cases of fecal impaction and, less commonly, ileus, bowel obstruction, and bowel perforation have been reported. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Sevelamer Hydrochloride Tablets, 800 mg, are supplied as off-white to pale yellow, modified capsule shaped, biconvex film coated tablets, imprinted with ‘G447’ on one side and plain on the other side and are supplied as follows: Unit dose packages of 100 (10 x 10) NDC 60687-449-01 Storage Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Do not use sevelamer hydrochloride tablets after the expiration date. Protect from moisture and store in a dry place. For your protection: Do not use if blister is torn or broken. (1.1)
Store Sevelamer Hydrochloride in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (sevelamer hydrochloride) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Kidney health medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Renagel (Sevelamer Hydrochloride), listed in Kidney health medications
- Cyclosporine, listed in Kidney health medications
- Cytra K (Potassium Citrate / Citric Acid), listed in Kidney health medications
- Darifenacin Hydrobromide, listed in Kidney health medications
- Calcijex (Calcitriol), listed in Kidney health medications
- Cystistat (Hyaluronate Sodium), listed in Kidney health medications
Related Categories, Directories, and Ordering Guides
- Kidney health medications Category Directory
- Medications Starting with S
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
- Explore Coumadin Warfarin Sodium
- Explore Warfarin Generic
- Explore Cardiovascular
- Explore Lanoxin Digoxin
- Explore Digoxin Generic
Frequently Asked Questions About Sevelamer Hydrochloride
What is Sevelamer Hydrochloride and what active ingredient does it contain?
Sevelamer Hydrochloride is a kidney health medications agent containing the active pharmaceutical ingredient sevelamer hydrochloride. It is supplied for oral administration and requires a valid prescription where applicable.
How does Sevelamer Hydrochloride work in the body?
Sevelamer hydrochloride tablets contain sevelamer hydrochloride, a non-absorbed binding crosslinked polymer. It contains multiple amines separated by one carbon from the polymer backbone. These amines exist in a protonated form in the intestine and interact with phosphate molecules through ionic and hydrogen bonding.
What conditions is Sevelamer Hydrochloride prescribed to treat?
Sevelamer Hydrochloride is primarily indicated for specified kidney-related conditions. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Sevelamer Hydrochloride?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Sevelamer Hydrochloride is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Sevelamer Hydrochloride?
Commonly reported side effects of Sevelamer Hydrochloride include feeling sick, vomiting, loose stools, constipation, abdominal pain, and tiredness. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Sevelamer Hydrochloride?
Important interaction categories for Sevelamer Hydrochloride include warfarin, digoxin, and cyclosporine. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Sevelamer Hydrochloride be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Sevelamer Hydrochloride to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Sevelamer Hydrochloride online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Sevelamer Hydrochloride (Sevelamer) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
What is the brand-name version of Sevelamer Hydrochloride (Sevelamer) at a Canada pharmacy?
How is Sevelamer Hydrochloride shipped to U.S. residents, and how much does shipping cost?
Sevelamer Hydrochloride ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Sevelamer Hydrochloride prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Sevelamer Hydrochloride prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Sevelamer Hydrochloride are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Sevelamer Hydrochloride. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Chronic Kidney Disease. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
